Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTND1P3 (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 3) is classified as a pseudogene in the human genome. Pseudogenes such as MTND1P3 are typically non-coding, lack the ability to produce a functional protein, and are generally considered non-functional remnants of genes that have lost their protein-coding ability or cannot be expressed in cells. MTND1P3 has no documented biological functions, disease associations, or role as a therapeutic target. It is distinct from the functional MT-ND1 gene, which encodes a core subunit of mitochondrial Complex I and is involved in the mitochondrial respiratory chain. MTND1P3 should not be confused with MT-ND1 or related functional genes associated with mitochondrial function and disease. MTND1P3 is not a therapeutic target, receptor, or enzyme. It is listed as a pseudogene in genetic databases and has no known clinical significance.
None (not a functional gene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 3 (MTND1P3).